elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q40456744-C4E16E57-D1A5-416D-910B-D149EE4584B7
Q40456744-C4E16E57-D1A5-416D-910B-D149EE4584B7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40456744-C4E16E57-D1A5-416D-910B-D149EE4584B7
A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial.
P2860
Q40456744-C4E16E57-D1A5-416D-910B-D149EE4584B7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40456744-C4E16E57-D1A5-416D-910B-D149EE4584B7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f9e6b475aeb37b8305cd55ad8f4ea95c4a7468bc
P2860
Prophylaxis of venous thromboembolism with subcutaneous melagatran in total hip or total knee replacement: results from Phase II studies.